Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Bristol Myers Squibb Stock Bounced Higher Today


Shares of Bristol Myers Squibb (NYSE: BMY) were bouncing 3.4% higher as of 3:31 p.m. ET on Thursday after slipping a little earlier this week. The big drugmaker didn't report any news that served as a catalyst. Instead, today's move appeared to be the result of investors seeking relatively safe stocks as the Nasdaq Composite index and Russell 2000 small-cap index fell.

Bristol Myers Squibb has seemed to be sort of a safe haven for investors throughout much of 2022. The pharma stock is up 15% year to date while the major market indexes have plunged.

The company hasn't delivered all that impressive top-line results, though. BMS' revenue rose by only 2% year over year in the second quarter. However, its bottom line looked better with Q2 adjusted earnings per share jumping 18%. 

Continue reading


Source Fool.com

Like: 0
BMY
Share

Comments